AME 359

Drug Profile

AME 359

Latest Information Update: 23 Mar 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Applied Molecular Evolution
  • Class Cholinesterases
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cocaine abuse

Most Recent Events

  • 23 Mar 2009 Discontinued - Preclinical for Cocaine abuse in USA (unspecified route)
  • 25 Feb 2004 Applied Molecular Evolution was acquired by Eli Lilly
  • 12 Feb 2003 Preclinical trials in Cocaine abuse in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top